Literature DB >> 23594031

Prognostic accuracy of continuous glucose monitoring in the prediction of diabetes mellitus in children with incidental hyperglycemia: receiver operating characteristic analysis.

Davide Brancato1, Gabriella Saura, Mattia Fleres, Lidia Ferrara, Alessandro Scorsone, Vito Aiello, Anna Di Noto, Lucia Spano, Vincenzo Provenzano.   

Abstract

AIM: The purpose of this study is to evaluate continuous glucose monitoring (CGM) in predicting diabetes mellitus in children with incident hyperglycemia (IH) and negativity for some insular autoantibodies. SUBJECTS AND METHODS: Thirty-one autoantibody-negative children who presented at our center with IH underwent a baseline assessment and were followed up for 23.8 months (range, 6-48 months). At the end of the follow-up, we compared the receiver operating characteristic (ROC) areas under the curve (AUCs) of metabolic markers from 17 children who developed diabetes (Group A; n=17) and 14 children who did not develop diabetes (Group B; n=14).
RESULTS: Only two oral glucose tolerance test (OGTT)-derived markers and three CGM-derived markers showed a good prognostic performance, with ROC AUCs indicating significant results (P<0.0001) for the following markers: 2-h glucose, OGTT (0.813; 95% confidence interval [CI] 0.621-0.954); AUC glucose, OGTT (0.832; 95% CI 0.611-0.950); CGM glucose measurement peak (0.803; 95% CI 0.621-0.923); percentage of CGM glucose measurements inside the range 70-125 mg/dL (0.866; 95% CI 0.695-0.961); and percentage of CGM measurements ≥126 mg/dL (0.889; 95% CI 0.724-0.973). The combination of the OGTT-derived markers did not increase the predictive value, but the combination of CGM markers with each other or with the OGTT markers yielded higher ROC AUCs (ranging from 0.828 to 0.945).
CONCLUSIONS: This is the first study showing that CGM is useful in predicting diabetes mellitus in children with IH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594031     DOI: 10.1089/dia.2013.0030

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  4 in total

1.  Continuous glucose monitoring in 2013.

Authors:  Tadej Battelino; Bruce W Bode
Journal:  Diabetes Technol Ther       Date:  2014-02       Impact factor: 6.118

2.  Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.

Authors:  Annelien Van Dalem; Simke Demeester; Eric V Balti; Katelijn Decochez; Ilse Weets; Evy Vandemeulebroucke; Ursule Van de Velde; An Walgraeve; Nicole Seret; Christophe De Block; Johannes Ruige; Pieter Gillard; Bart Keymeulen; Daniel G Pipeleers; Frans K Gorus
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

3.  The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus.

Authors:  Davide Brancato; Mattia Fleres; Vito Aiello; Gabriella Saura; Alessandro Scorsone; Lidia Ferrara; Francesca Provenzano; Anna Di Noto; Lucia Spano; Vincenzo Provenzano
Journal:  Diabetes Technol Ther       Date:  2014-08-27       Impact factor: 6.118

4.  Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes.

Authors:  A Zmyslowska; W Fendler; A Szadkowska; M Borowiec; M Mysliwiec; A Baranowska-Jazwiecka; M Buraczewska; M Fulmanska-Anders; B Mianowska; I Pietrzak; D Rzeznik; W Mlynarski
Journal:  Acta Diabetol       Date:  2015-04-29       Impact factor: 4.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.